Jane Street’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.2M | Buy |
157,500
+25,215
| +19% | +$4.14M | ﹤0.01% | 1548 |
|
|
2025
Q4 | $21.1M | Sell |
132,285
-117,985
| -47% | -$16.2M | ﹤0.01% | 1581 |
|
|
2025
Q3 | $23.4M | Buy |
250,270
+86,795
| +53% | +$6.13M | ﹤0.01% | 1508 |
|
|
2025
Q2 | $9.3M | Buy |
163,475
+24,700
| +18% | +$1.31M | ﹤0.01% | 2232 |
|
|
2025
Q1 | $8.46M | Sell |
138,775
-32,675
| -19% | -$2.78M | ﹤0.01% | 2200 |
|
|
2024
Q4 | $15.4M | Sell |
171,450
-2,700
| -2% | -$318K | ﹤0.01% | 1482 |
|
|
2024
Q3 | $22.4M | Buy |
+174,150
| New | +$22.7M | ﹤0.01% | 1159 |
|
|
2022
Q2 | – | Sell |
-3,625
| Closed | -$1.14M | – | 10345 |
|
|
2022
Q1 | $1.14M | Sell |
3,625
-16,240
| -82% | -$6.12M | ﹤0.01% | 5869 |
|
|
2021
Q4 | $14.3M | Buy |
19,865
+4,720
| +31% | +$4.52M | ﹤0.01% | 1487 |
|
|
2021
Q3 | $16.8M | Buy |
15,145
+3,865
| +34% | +$4.75M | 0.01% | 1262 |
|
|
2021
Q2 | $16.6M | Buy |
11,280
+3,375
| +43% | +$4.68M | 0.01% | 1239 |
|
|
2021
Q1 | $12.5M | Sell |
7,905
-5,350
| -40% | -$12.5M | 0.01% | 1350 |
|
|
2020
Q4 | $26.6M | Sell |
13,255
-4,395
| -25% | -$7.01M | 0.01% | 705 |
|
|
2020
Q3 | $18.9M | Sell |
17,650
-3,660
| -17% | -$4.2M | 0.01% | 809 |
|
|
2020
Q2 | $25.3M | Buy |
21,310
+13,035
| +158% | +$11.3M | 0.02% | 638 |
|
|
2020
Q1 | $3.73M | Sell |
8,275
-3,880
| -32% | -$3.53M | ﹤0.01% | 1414 |
|
|
2019
Q4 | $14M | Sell |
12,155
-4,505
| -27% | -$4.04M | 0.02% | 503 |
|
|
2019
Q3 | $10.3M | Sell |
16,660
-6,780
| -29% | -$5.63M | 0.02% | 589 |
|
|
2019
Q2 | $23.5M | Buy |
23,440
+260
| +1% | +$252K | 0.04% | 330 |
|
|
2019
Q1 | $27.8M | Buy |
23,180
+11,535
| +99% | +$12M | 0.05% | 315 |
|
|
2018
Q4 | $7.65M | Buy |
11,645
+150
| +1% | +$157K | 0.02% | 714 |
|
|
2018
Q3 | $21.4M | Buy |
11,495
+4,075
| +55% | +$8M | 0.04% | 310 |
|
|
2018
Q2 | $14.1M | Buy |
7,420
+505
| +7% | +$890K | 0.03% | 449 |
|
|
2018
Q1 | $11M | Buy |
6,915
+4,005
| +138% | +$7.46M | 0.03% | 501 |
|
|
2017
Q4 | $4.53M | Sell |
2,910
-4,930
| -63% | -$7.55M | 0.01% | 937 |
|
|
2017
Q3 | $13.4M | Buy |
7,840
+175
| +2% | +$243K | 0.04% | 407 |
|
|
2017
Q2 | $9.67M | Buy |
7,665
+2,470
| +48% | +$2.49M | 0.03% | 474 |
|
|
2017
Q1 | $4.96M | Sell |
5,195
-3,190
| -38% | -$2.84M | 0.02% | 711 |
|
|
2016
Q4 | $5.25M | Buy |
8,385
+1,190
| +17% | +$894K | 0.02% | 636 |
|
|
2016
Q3 | $7.02M | Sell |
7,195
-7,643
| -52% | -$6.31M | 0.03% | 433 |
|
|
2016
Q2 | $8.37M | Buy |
14,838
+4,215
| +40% | +$2.64M | 0.04% | 399 |
|
|
2016
Q1 | $5.83M | Buy |
10,623
+8,312
| +360% | +$5.26M | 0.03% | 491 |
|
|
2015
Q4 | $3.9M | Buy |
+2,311
| New | +$3.74M | 0.02% | 623 |
|
Other funds holding LABU
JF
TRCT
XT
HF
MIG
TSS
Jane Street's LABU Position: Q2 2025 in Review
Jane Street sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 73,118 shares — an estimated $3.88M sold.
Jane Street first reported a position in LABU in Q3 2015 and held it in 32 quarters. The position peaked at $9.92M in Q4 2023. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.
- Jane Street reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
- Jane Street sold 73,118 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $3.88M.
- Jane Street first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2015 and held it in 32 quarters.
- Jane Street's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.92M in Q4 2023.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.